LEIDEN, NL
ZoBio, a boutique problem-solving Contract Research Organization (CRO) specializing in early gene-to-lead discovery, today announced the launch of its comprehensive…
Expanding Isotopic Labeling in Mammalian Expression: Pushing the Boundaries on NMR Studies of Hard-to-Express Proteins
ZoBio is excited to expand its exclusive capability for making complex protein samples for drug discovery with 13C-methyl MILV isotopic labeling during HEK293 mammalian…
Lipids Make a Difference: Local Collaboration Advances Drug Discovery for Membrane Proteins
Membrane proteins are without a doubt an important drug target: about 60% of all confirmed drug targets are located on the cell surface. However, studying these proteins in vitro has long been challenging due to…
Tackling the Hard-to-Drug Frontier: The Power of Complementary Screening Modalities
Developing small-molecule drugs for hard-to-drug targets remains one of the toughest challenges in modern drug discovery. Targets like cytokines, transcription factors, and scaffolding proteins often lack well-defined…